ADD, ADHD drug Cylert to be pulled - danger to liver

Attention deficit drug to be pulled from market

Manufacturer says it plans to discontinue Cylert

The Associated Press
Updated: 4:36 p.m. ET March 25, 2005

WASHINGTON - A drug that has been used for attention deficit hyperactivity disorder for 30 years is being discontinued.

The consumer group Public Citizen petitioned the Food and Drug Administration on Thursday, asking the agency to ban pemoline, also sold under the trade name Cylert, because of reported cases of liver damage in users.

Abbott Laboratories, the manufacturer of Cylert, said it is already planning to discontinue the drug because of declining sales.

Pemoline was approved in 1975. Since then other drugs, including generics, have become available to treat ADHD. Cylert sales were less than $1 million last year.
The company said letters advising physicians that the drug is being discontinued will go out within two months, and they will be given time to change patients to other drugs.

In its petition, Public Citizen said the drug has been withdrawn in the United Kingdom and Canada and carries two separate label warnings in this country.
Between the 1975 approval and 1996, there were 193 adverse drug reactions involving the liver ascribed to pemoline, including 13 cases of acute liver failure, Public Citizen said.
© 2005 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

--------

K - have you noticed that so many of the dangerous and banned pills have "damage to the liver" as the problem?
Sure, the liver is where toxins go to. The odd thing is that they know this, so they could look there and see the damage LONG BEFORE NOW. They must have known 20 years ago.

Like Vioxx, the dangers were known and they continued to push them, even claiming safety when they knew the opposite is true.

We cannot tolerate these players in the medical game anymore. They have proven themselves to be dangerous to our health, to be liars over the most crucial aspects of health.
Tweet